Prolactin deficiency is independently associated with reduced insulin-like growth factor I status in severely growth hormone-deficient adults

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 7, 2006, Pages 2520-2525

  Mukherjee, A ^a   Ryder, W D J ^a   Jostel A ^a   Shalet, S M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; SOMATOMEDIN C;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CHILDHOOD; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE DEFICIENCY; HUMAN; HYPOPHYSIS DISEASE; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; HYPOTHALAMIC DISEASES; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PROLACTIN; REGRESSION ANALYSIS;

EID: 33745803638     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2491     Document Type: Article

References (33)

1. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KK 1994 Diagnosis of growth-hormone deficiency in adults. Lancet 343:1064-1068
2. Juul A, Holm K, Kastrup KW, Pedersen SA, Michaelsen KF, Scheike T, Rasmussen S, Muller J, Skakkebaek NE 1997 Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab 82:2497-2502
3. Shalet SM, Toogood A, Rahim A, Brennan BM 1998 The diagnosis of growth hormone deficiency in children and adults. Endocr Rev 19:203-223
4. Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG 2001 Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. J Clin Endocrinol Metab 86:3001-3008
5. Mukherjee A, Monson JP, Jonsson PJ, Trainer PJ, Shalet SM 2003 Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders. J Clin Endocrinol Metab 88:5865-5870
6. Hall K, Hilding A, Thoren M 1999 Determinants of circulating insulin-like growth factor-I. J Endocrinol Invest 22:48-57
7. Janssen YJ, Frolich M, Roelfsema F 1997 A low starting dose of genotropin in growth hormone-deficient adults. J Clin Endocrinol Metab 82:129-135
8. Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA 1997 Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 82:550-555
9. Svensson J, Johannsson G, Bengtsson BA 1997 Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test. Clin Endocrinol (Oxf) 46:579-586
10. Drake WM, Coyte D, Camacho-Hubner C, Jivanji NM, Kaltsas G, Wood DF, Trainer PJ, Grossman AB, Besser GM, Monson JP 1998 Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 83:3913-3919
11. Hilding A, Hall K, Wivall-Helleryd IL, Saaf M, Melin AL, Thoren M 1999 Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 84:2013-2019
12. Span JP, Pieters GF, Sweep CG, Hermus AR, Smals AG 2000 Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. J Clin Endocrinol Metab 85:1121-1125
13. Murray RD, Howell SJ, Lissett CA, Shalet SM 2000 Pre-treatment IGF-I level is the major determinant of GH dosage in adult GH deficiency. Clin Endocrinol (Oxf) 52:537-542
14. Lissett CA, Murray RD, Shalet SM 2002 Timing of onset of growth hormone deficiency is a major influence on insulin-like growth factor I status in adult life. Clin Endocrinol (Oxf) 57:35-40
15. Lissett CA, Jonsson P, Monson JP, Shalet SM 2003 Determinants of IGF-I status in a large cohort of growth hormone-deficient (GHD) subjects: the role of timing of onset of GHD. Clin Endocrinol (Oxf) 59:773-778
16. Jorgensen JO, Christensen JJ, Krag M, Fisker S, Ovesen P, Christiansen JS 2004 Serum insulin-like growth factor I levels in growth hormone-deficient adults: influence of sex steroids. Horm Res 62:73-76
17. Miller WL, Eberhardt NL 1983 Structure and evolution of the growth hormone gene family. Endocr Rev 4:97-130
18. Nicoll CS, Mayer GL, Russell SM 1986 Structural features of prolactins and growth hormones that can be related to their biological properties. Endocr Rev 7:169-203
19. Goffin V, Shiverick KT, Kelly PA, Martial JA 1996 Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr Rev 17:385-410
20. Hill DJ, Francis MJ, Milner RD 1977 Action of rat prolactin on plasma somatomedin levels in the rat and on somatomedin release from perfused rat liver. J Endocrinol 75:137-143
21. Crowe PD, Buckley AR, Zorn NE, Rui H 1991 Prolactin activates protein kinase C and stimulates growth-related gene expression in rat liver. Mol Cell Endocrinol 79:29-35
22. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA 1998 Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225-268
23. Andersen B, Rosenfeld MG 2001 POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocr Rev 22:2-35
24. Brabant G, von zur Muhlen A, Wuster C, Ranke MB, Kratzsch J, Kiess W, Ketelslegers JM, Wilhelmsen L, Hulthen L, Saller B, Mattsson A, Wilde J, Schemer R, Kann P 2003 Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res 60:53-60
25. Cleveland WS 1979 Robust locally-weighted regression and smoothing scatterplots. J Am Statist Assoc 74:829-836
26. MathSoft 2000 S-PLUS: guide to statistics. Vol. 1. Seattle: MathSoft
27. Mukherjee A, Murray RD, Teasdale GM, Shalet SM 2004 Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Clin Endocrinol (Oxf) 60:476-483
28. Toogood AA, Beardwell CG, Shalet SM 1994 The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol (Oxf) 41:511-516
29. Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ 2002 Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 87:477-485
30. Francis MJ, Hill DJ 1975 Prolactin-stimulated production of somatomedin by rat liver. Nature 255:167-168
31. Sauro MD, Bing B, Zorn NE 1992 Prolactin induces growth-related gene expression in rat aortic smooth muscle in vivo. Eur J Pharmacol 225:351-354
32. Clemmons DR, Underwood LE, Ridgway EC, Kliman B, Van Wyk JJ 1981 Hyperprolactinemia is associated with increased immunoreactive somatomedin C in hypopituitarism. J Clin Endocrinol Metab 52:731-735
33. Goffin V, Bernichtein S, Touraine P, Kelly PA 2005 Development and potential clinical uses of human prolactin receptor antagonists. Endocr Rev 26:400-422